Avecho Biotechnology Archives | Page 2 of 4 | Cannabiz

Big pharma makes CBD over-the-counter move as Sandoz strikes 10-year deal with Avecho

by Steve Jones March 3, 2025April 29, 2026

Pharmaceutical firm Sandoz has invested an initial A$4.8 million in Avecho’s attempt to register an over-the-counter […]

Company news: Rua Bioscience; Avecho; Bioxyne/BLS; iX Biopharma; Ecofibre; Zelira

by Steve Jones and Martin Lane August 28, 2024January 13, 2025

Company news: Avecho; Bioxyne; Elixinol Wellness; IDT Australia; Melodiol Global Health; Zelira

by Steve Jones July 31, 2024November 25, 2024

Company news: AusCann; Avecho; Melodiol Global Health

by Steve Jones April 30, 2024July 16, 2024

Recruitment for Avecho’s sleep trial gets underway

by Martin Lane March 26, 2024July 16, 2024

Avecho gets go ahead for Phase III sleep trial

by Martin Lane March 7, 2024July 16, 2024

Financial results: Bioxyne; Rua Bioscience; Bod Science; Avecho; Wellnex Life; MGC Pharma; Cannasouth

by Steve Jones March 7, 2024March 7, 2024

Quarterly results: Avecho; Melodiol; Bioxyne/BLS; Emyria; Ecofibre; Zelira; Elixinol; AusCann; Botanix

by Steve Jones and Martin Lane January 31, 2024July 11, 2024

Financial results: Avecho; Wellnex; Zelira; Emyria; Botanix; MGC Pharma; AusCann; Epsilon; Melodiol; Bioxyne

by Martin Lane and Steve Jones September 4, 2023April 30, 2024

Avecho raises another A$6m to fund trial as firm enters ‘defining chapter’

by Steve Jones August 28, 2023April 30, 2024